Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Fadlyana E, Setiabudi D, Kartasasmita CB, Putri ND, et al. Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial Lancet Infect Dis 2023 Jan 11:S1473-3099(22)00800.
PMID: 36640798


Privacy Policy